ClinConnect ClinConnect Logo
Search / Trial NCT06501729

Kissing As a Protective Factor Against Acidic PH in Saliva

Launched by UNIVERSIDAD CATOLICA SANTIAGO DE GUAYAQUIL · Jul 9, 2024

Trial Information

Current as of July 04, 2025

Enrolling by invitation

Keywords

Saliva Hydrogen Ion Concentration Dental Caries

ClinConnect Summary

The goal of this intervention study will be to determine if oral kissing between two people can increase salivary pH more quickly after drinking artificial juices, soft drinks, or (non-alcoholic) beers. It will also be studied whether the pH restoration time is faster when only one person kisses one of the named drinks or when both people do it. The main questions that are intended to be answered are the following:

* Is the act of kissing on the mouth capable of increasing the pH of saliva more quickly than physiologically after consuming a sugary or fermented drink that has decreased it?
...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • They must be in good health
  • They must have good oral health according to the raised loss and observed index.
  • They will be between 18 and 30 years old to reduce the probability of consuming medications that alter salivary pH.
  • Exclusion Criteria:
  • Be taking medications that alter the pH of saliva.
  • Have abscesses in the oral cavity

About Universidad Catolica Santiago De Guayaquil

Universidad Católica Santiago de Guayaquil (UCSG) is a leading institution dedicated to advancing medical research and education in Ecuador. As a clinical trial sponsor, UCSG is committed to fostering innovative healthcare solutions through rigorous scientific investigation and collaboration with healthcare professionals. With a focus on ethical practices and patient safety, UCSG aims to contribute to the development of new therapies and improve health outcomes in the community. The university leverages its academic resources and expertise to support clinical trials that address pressing medical challenges, reinforcing its role as a pivotal player in the region's health research landscape.

Locations

Guayaquil, Guayas, Ecuador

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported